Hybrid deep learning system improves skin lesion diagnosis accuracy, suggesting benefits for patient outcomes.
Skin cancer, one of the most prevalent forms of cancer globally, demands early and accurate diagnosis to improve patient outcomes. In this paper, we present DermAssist , a hybrid deep learning-based dermatology assistant system that integrates Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) for automated multi-class skin lesion classification. Our model was trained and evaluated on widely-used datasets including DermNet, ISIC, and HAM10000, employing a robust preprocessing pipeline to enhance lesion visibility and diversity. DermAssist combines segmentation (U-Net), feature extraction (ResNet), and classification (BEiT Transformer), and introduces a dual-portal architecture for clinicians and patients using Streamlit and Flask interfaces. We incorporate Grad-CAM and SHAP for interpretability, Twilio-based SMS alerting for high-risk cases ( > 90% confidence), and secure AWS S3 storage to ensure HIPAA compliance. Experimental results demonstrate an accuracy of 90.2% with strong ROC-AUC and precision scores. DermAssist is positioned as a deployable, intelligent diagnostic aid capable of enhancing dermatological workflows in real-time environments.
No takes yet. Share an insight, caveat, or question.
S. F. B. Nasir (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: